CBM

Cambrex Corporation

CBM

Overview Fund Trends Analyst Outlook Journalist POV

Delisted

CBM was delisted on the 3rd of December, 2019.

Back to rankings

Positive

Neutral

Negative

Sentiment 3-Months

Positive

Neutral 0%

Negative

Permira seeks $4 billion for sale of contract drugmaker Cambrex, FT reports

British private equity firm Permira has put its contract drugmaker Cambrex up for sale, targeting a valuation of as much as $4 billion, the Financial Times reported on Saturday, citing people familiar with the matter.

Permira seeks $4 billion for sale of contract drugmaker Cambrex, FT reports

Semi-Solid Dosage CDMO Market Report 2024-2030: The Lubrizol Corporation, Cambrex Corporation, and Contract Pharmaceuticals Dominate the Competitive Landscape

Dublin, Nov. 13, 2024 (GLOBE NEWSWIRE) -- The "Semi-Solid Dosage CDMO Market Size, Share & Trends Analysis by Route of Administration (Topical, Transdermal, Others), Product, Service, End-use, and Country, 2024-2030" report has been added to ResearchAndMarkets.com's offering. The global semi-solid Dosage CDMO market is expected to reach USD 67.4 billion by 2030, and anticipated to grow at a CAGR of 11.80% from 2024 to 2030.

Semi-Solid Dosage CDMO Market Report 2024-2030: The Lubrizol Corporation, Cambrex Corporation, and Contract Pharmaceuticals Dominate the Competitive Landscape

See News Rankings